PSPC1 and cancer: This model confirms that IH potentiates the effect of PSPC1 on TGFβ and that PSPC1 has a paracrine effect on the expression of EMT transcription factors by cancer cells, both when it is used as a recombinant protein and when used in the plasma from patients with OSA without evidence of cancer.